TickerFacts.

Company research / LMAT

Lemaitre Vascular Inc (LMAT)

Build a valuation ↗↓ Download CSV

SEC name LEMAITRE VASCULAR INC · CIK 0001158895 · Nasdaq · Surgical & Medical Instruments & Apparatus

  • Sector Manufacturing
  • Fiscal year ends Dec 31

For the year ended 2025-12-31, Lemaitre Vascular Inc reported revenue of $249.60M. Revenue grew 13.5% from the prior annual period. Over the twelve months to 2026-06-30, revenue was $262.43M.

Key ratios (year ended 2025-12-31)

71.5%
Gross margin
27.2%
Operating margin
23.1%
Net margin
14.7%
Return on year-end equity
13.5%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 8-K (current report) · 2026-10-15

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-06-30 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period endedTTM to
2026-06-30		2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Revenue$262.43M$249.60M$219.86M$193.48M$161.65M$154.42M$129.37M$117.23M$105.57M$100.87M$89.15M
Cost of Revenue$71.13M$71.06M$68.96M$66.44M$56.76M$53.04M$44.75M$37.38M$31.63M$30.17M$26.21M
Gross Profit$191.31M$178.54M$150.90M$127.05M$104.90M$101.38M$84.62M$79.85M$73.94M$70.70M$62.94M
R&D Expense$15.41M$14.14M$15.65M$16.97M$13.29M$11.80M$10.10M$9.28M$8.20M$6.64M$6.14M
Operating Income$77.32M$67.91M$52.26M$36.71M$26.83M$36.42M$28.79M$21.18M$28.21M$21.10M$16.34M
Depreciation & Amortization$10.50M$10.42M$9.61M$9.52M$9.43M$11.07M$8.39M$5.42M$4.32M$4.05M$3.59M
EBITDA$87.82M$78.33M$61.86M$46.23M$36.26M$47.49M$37.18M$26.60M$32.53M$25.16M$19.93M
Net Income$65.67M$57.73M$44.04M$30.11M$20.64M$26.91M$21.22M$17.93M$22.94M$17.18M$10.59M
EPS (Diluted)n/a$2.52$1.93$1.34$0.93$1.25$1.04$0.88$1.13$0.86$0.55
Total Assets$640.55M$615.69M$551.82M$346.78M$310.48M$292.80M$252.81M$188.34M$153.09M$126.32M$101.92M
Total Liabilities$220.21M$222.17M$214.53M$48.88M$42.27M$38.65M$80.24M$40.20M$22.85M$16.55M$14.42M
Shareholders' Equity$420.34M$393.52M$337.29M$297.90M$268.20M$254.15M$172.57M$148.14M$130.24M$109.77M$87.50M
Cash & Equivalents$26.62M$28.24M$25.61M$24.27M$19.13M$13.86M$26.76M$11.79M$26.32M$19.10M$24.29M
Operating Cash Flow$82.98M$81.25M$44.12M$36.75M$25.38M$35.10M$34.80M$14.18M$19.51M$22.87M$16.90M
Capital Expenditures$9.15M$6.78M$6.96M$7.26M$3.23M$4.88M$2.98M$3.76M$3.05M$6.42M$2.84M
Free Cash Flow$73.83M$74.47M$37.16M$29.49M$22.15M$30.22M$31.82M$10.42M$16.45M$16.45M$14.05M
Share Repurchases$1.69M$1.82M$1.72M$853.0K$642.0K$802.0K$570.0K$683.0K$741.0K$778.0K$311.0K
Dividends Paid$20.50M$18.11M$14.38M$12.45M$10.99M$9.34M$7.70M$6.74M$5.45M$4.18M$3.32M
Shares Outstanding22.86M22.77M22.55Mn/an/an/an/an/an/an/an/a
Dividends Per Sharen/a$0.80$0.64$0.56$0.50$0.44$0.38$0.34$0.28$0.22$0.18
Weighted Average Diluted Sharesn/a22.93M22.78M22.42M22.17M21.48M20.48M20.33M20.24M20.03M19.24M
EPS (Basic)n/a$2.55$1.96$1.36$0.94$1.27$1.05$0.91$1.18$0.91$0.57

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView